Cancer API Market Size, Share, Trends & Forecast
The Cancer API Market is expanding as pharmaceutical companies increase investment in active pharmaceutical ingredients used for innovative and generic cancer therapies. Market Research Future estimates that the market was valued at USD 48.81 billion in 2024 and is projected to reach USD 90.21 billion by 2035, registering a CAGR of 5.74% during 2025–2035.
Rising cancer incidence, advances in biotechnology, and growing demand for targeted therapies are supporting market development. Pharmaceutical manufacturers are increasingly focused on developing APIs that can support more precise treatment strategies.
The shift toward personalized medicine is also influencing oncology drug development. Genetic and molecular profiling can help identify appropriate treatment approaches, increasing demand for APIs associated with targeted cancer therapies.